Reducing the risk of human and antihuman antibodies through V gene manipulation

Details for Australian Patent Application No. 2005227313 (hide)

Owner Abgenix, Inc.

Inventors Green, Larry L.; Korver, Wouter; Kellermann, Sirid-Aimee

Agent Davies Collison Cave

Pub. Number AU-A-2005227313

PCT Pub. Number WO2005/092926

Priority 60/554,372 19.03.04 US; 60/574,661 24.05.04 US

Filing date 17 March 2005

Wipo publication date 6 October 2005

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

12 October 2006 PCT application entered the National Phase

  PCT publication WO2005/092926 Priority application(s): WO2005/092926

30 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(c). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005227314-Improved process for the preparation of 9,11 epoxy steroids

2005227312-Development and use of fluorescent probes of unbound analytes